Trietsch Sebastiaan J

Sebastiaan J. Trietsch was born in The Hague, The Netherlands, in 1985. He received the M.Sc. degree in biopharmaceutical sciences, with a specialization in analytical chemistry, from the Leiden Academic Center for Drug Research (LACDR), Leiden University, Leiden, The Netherlands, and the Ph.D. degree from the Division of Analytical Biosciences, LACDR, with a focus on microfluidic technology for 3-D cell culture and resulted in the development of the OrganoPlate, a microfluidic platform for high throughput 3-D cell culture. He was with the Faculty of Pharmacy, The University of Sydney, Sydney, NSW, Australia, where he researched electrostatic charge characteristics of inhalation medicine. He has a wide range of experience ranging from drug development and complex cell culture to microfabrication and high content imaging. He is a Co-Founder and the Chief Technology Officer at Mimetas B.V.-The Organ-on-a-Chip Company, Leiden, which markets and further develops the OrganoPlate. His research was published in over 20 peer-reviewed papers and patents.